QT
ACOR

Quantbot Technologies’s Acorda Therapeutics ACOR Stock Holding History

Quantbot Technologies’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-219
Closed -$75K – 1685
2019
Q3 		$75K Buy
219
+190
+655% +$103K 0.01% 892
2019
Q2 		$26K Buy
+29
New +$35.6K ﹤0.01% 1002
2018
Q4 		– Sell
-72
Closed -$170K – 1517
2018
Q3 		$170K Buy
+72
New +$223K 0.01% 770
2017
Q4 		– Sell
-12
Closed -$35K – 1551
2017
Q3 		$35K Buy
+12
New +$31.6K ﹤0.01% 1002
2017
Q2 		– Sell
-56
Closed -$142K – 1460
2017
Q1 		$142K Sell
56
-66
-54% -$190K 0.01% 715
2016
Q4 		$274K Sell
122
-14
-10% -$33.3K 0.03% 481
2016
Q3 		$340K Buy
136
+7
+5% +$20.9K 0.04% 437
2016
Q2 		$395K Buy
+129
New +$420K 0.04% 422
2016
Q1 		– Sell
-21
Closed -$109K – 1471
2015
Q4 		$109K Buy
21
+16
+320% +$69.9K 0.02% 627
2015
Q3 		$15K Buy
+5
New +$19.4K ﹤0.01% 1050
2015
Q2 		– Sell
-10
Closed -$39K – 1430
2015
Q1 		$39K Buy
+10
New +$45.8K 0.01% 824
2014
Q4 		– Sell
-73
Closed -$298K – 1471
2014
Q3 		$298K Buy
+73
New +$274K 0.04% 548
2014
Q1 		– Sell
-48
Closed -$169K – 1403
2013
Q4 		$169K Buy
48
+41
+586% +$160K 0.08% 303
2013
Q3 		$27K Buy
+7
New +$30.2K 0.02% 623

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Quantbot Technologies's ACOR Position: Q4 2019 in Review

Quantbot Technologies sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 219 shares — an estimated $75K sold.

Quantbot Technologies first reported a position in ACOR in Q3 2013 and held it in 14 quarters. The position peaked at $395K in Q2 2016. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Quantbot Technologies reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Quantbot Technologies sold 219 Acorda Therapeutics shares in Q4 2019, an estimated $75K.
  • Quantbot Technologies first reported a position in Acorda Therapeutics in Q3 2013 and held it in 14 quarters.
  • Quantbot Technologies's Acorda Therapeutics position peaked at $395K in Q2 2016.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Quantbot Technologies's 13F filing for Q4 2019, filed 10 Feb 2020.